Chiome Bioscience Inc. (4583.T)
JPY 272.0
(-3.2%)
JPY 272.0
(-3.2%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 291 Million JPY | 58.15% |
| 2022 | 184 Million JPY | 0.55% |
| 2021 | 183 Million JPY | 1.67% |
| 2020 | 180 Million JPY | 0.0% |
| 2019 | - JPY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 292.1 Million JPY | -6.86% |
| 2024 Q1 | 313.6 Million JPY | 7.77% |
| 2023 FY | 291 Million JPY | 58.15% |
| 2023 Q2 | 298.3 Million JPY | -0.9% |
| 2023 Q1 | 301 Million JPY | 63.59% |
| 2023 Q3 | 316.3 Million JPY | 6.03% |
| 2023 Q4 | 291 Million JPY | -8.0% |
| 2022 Q3 | 188 Million JPY | 0.0% |
| 2022 Q4 | 184 Million JPY | -2.13% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 2.46 Billion JPY | 88.217% |
| PRISM BioLab Co.,LTD | - JPY | -Infinity% |
| GNI Group Ltd. | 3.69 Billion JPY | 92.134% |
| Linical Co., Ltd. | 3 Billion JPY | 90.306% |
| Trans Genic Inc. | 2.25 Billion JPY | 87.107% |
| MEDINET Co., Ltd. | 2.3 Million JPY | -12513.784% |
| Soiken Holdings Inc. | - JPY | -Infinity% |
| Cytori Cell Research Institute, Inc. | 2.47 Billion JPY | 88.227% |
| AnGes, Inc. | 362.67 Million JPY | 19.763% |
| OncoTherapy Science, Inc. | 106.84 Million JPY | -172.347% |
| Nxera Pharma Co., Ltd. | 73.97 Billion JPY | 99.607% |
| Immuno-Biological Laboratories Co., Ltd. | 235.98 Million JPY | -23.314% |
| NanoCarrier Co., Ltd. | 1.1 Billion JPY | 73.758% |
| Carna Biosciences, Inc. | 182.97 Million JPY | -59.042% |
| CanBas Co., Ltd. | - JPY | -Infinity% |
| D. Western Therapeutics Institute, Inc. | 885.12 Million JPY | 67.123% |
| RaQualia Pharma Inc. | 367.71 Million JPY | 20.863% |
| Kidswell Bio Corporation | 2.57 Billion JPY | 88.699% |
| PeptiDream Inc. | 22.79 Billion JPY | 98.724% |
| Oncolys BioPharma Inc. | 315.17 Million JPY | 7.669% |
| Ribomic Inc. | - JPY | -Infinity% |
| SanBio Company Limited | 665 Million JPY | 56.241% |
| Healios K.K. | 4.53 Billion JPY | 93.579% |
| BrightPath Biotherapeutics Co., Ltd. | 112.5 Million JPY | -158.667% |
| Kubota Pharmaceutical Holdings Co., Ltd. | 142.85 Million JPY | -103.706% |
| Delta-Fly Pharma, Inc. | - JPY | -Infinity% |
| StemRIM | - JPY | -Infinity% |
| CellSource Co., Ltd. | 97.54 Million JPY | -198.333% |
| FunPep Company Limited | - JPY | -Infinity% |
| Kringle Pharma, Inc. | - JPY | -Infinity% |
| Stella Pharma Corporation | 933.3 Million JPY | 68.82% |
| TMS Co., Ltd. | - JPY | -Infinity% |
| Noile-Immune Biotech Inc. | - JPY | -Infinity% |
| Cuorips Inc. | - JPY | -Infinity% |
| K Pharma,Inc. | - JPY | -Infinity% |
| Takara Bio Inc. | 968 Million JPY | 69.938% |
| ReproCELL Incorporated | - JPY | -Infinity% |
| PhoenixBio Co., Ltd. | 723.93 Million JPY | 59.803% |
| StemCell Institute Inc. | 8.78 Million JPY | -3212.842% |
| Japan Tissue Engineering Co., Ltd. | - JPY | -Infinity% |
| CellSeed Inc. | 151.25 Million JPY | -92.397% |